Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pancreastatin molecular forms in normal human plasma

N Kitayama1, K Tateishi, A Funakoshi

  • 1First Department of Biochemistry, School of Medicine, Fukuoka University, Japan.

Life Sciences
|January 1, 1994
PubMed
Summary

Researchers identified larger molecular forms and human pancreastatin (hPST)-52 as key circulating pancreastatin forms in normal subjects. These forms may play significant physiological roles in human circulation.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correction to: A case of severe interstitial lung disease after COVID-19 vaccination.

QJM : monthly journal of the Association of Physicians·2022
Same author

Response to: Multisystem inflammatory syndrome following COVID-19 vaccination: ignored and underdiagnosed.

QJM : monthly journal of the Association of Physicians·2021
Same author

A case of severe interstitial lung disease after COVID-19 vaccination.

QJM : monthly journal of the Association of Physicians·2021
Same author

The Vitamin D3 analogue calcipotriol suppresses CpG-activated TLR9-MyD88 signalling in murine plasmacytoid dendritic cells.

Clinical and experimental dermatology·2018
Same author

Updated results from GEST study: a randomized, three-arm phase III study for advanced pancreatic cancer.

Journal of cancer research and clinical oncology·2017
Same author

Randomised phase II trial of S-1 plus oxaliplatin vs S-1 in patients with gemcitabine-refractory pancreatic cancer.

British journal of cancer·2015

Area of Science:

  • Endocrinology
  • Molecular Biology
  • Gastroenterology

Background:

  • Pancreastatin (PST) is a biologically active peptide derived from chromogranin-A.
  • Understanding the circulating forms of PST is crucial for its physiological and pathological roles.

Purpose of the Study:

  • To characterize the circulating molecular forms of pancreastatin (PST)-like immunoreactivity in human plasma.
  • To investigate the physiological significance of these circulating PST forms.

Main Methods:

  • Gel filtration chromatography of plasma from normal subjects.
  • High-performance liquid chromatography (HPLC) analysis.
  • Purification and biological activity assessment of PST forms from QGP-1N cell xenografts.

Main Results:

Related Experiment Videos

  • Detection of an hPST-52-like form and larger molecular weight forms (15-21 kDa) in normal plasma.
  • Predominant circulating forms coeluted with purified larger forms from QGP-1N cells and synthetic hPST-52.
  • Purified larger forms exhibited biological activity comparable to hPST-52 in inhibiting pancreatic exocrine secretion.

Conclusions:

  • Larger molecular forms and hPST-52 are significant circulating forms of PST in humans.
  • These identified forms are likely physiologically important in regulating pancreatic function.